Under Neutropenia section from Journal of Clinical Oncology published on May 2018 Neutropenia, a decrease in the absolute neutrophil count (ANC), occurs frequently in recipients of chemotherapy. In 2013, American Society of Clinical Oncology (ASCO) released a guideline on antimicrobial prophylaxis for febrile neutropenia, as well as recommendations for identifying patients with fever and neutropenia who may be treated as outpatients. This updated guideline includes new evidence on risk stratification of patients who are stable and at lower risk. What Is This Guideline About?
The American Society of Clinical Oncology (ASCO) in association with Infectious Diseases Society of American (IDSA) aimed at providing an updated guideline on outpatient management of fever and neutropenia in patients with cancer. What Was Need For Guideline? Neutrophils are critical in providing host defense…
